Latest Medtech News
CARPL.ai has raised $10 million in a Series A funding round led by the International Finance Corporation (IFC), with participation from Stellaris Venture Partners and other investors, to expand its radiology AI marketplace and enterprise platform.
The company’s vendor-neutral platform gives healthcare providers access to more than 300 AI applications from over 100 partners through a single integration, helping simplify the deployment, management, and governance of clinical AI. The new funding will support product innovation, global commercial expansion, and growth across North America, Europe, Asia-Pacific, LATAM, and emerging markets.
“Our mission is to ensure that clinicians can confidently utilize the absolute best AI technology available for their patients,” said Dr. Vidur Mahajan, CEO of CARPL.ai. “We are privileged to have International Finance Corporation as a partner as we grow across the world.”
While initially focused on radiology, CARPL.ai plans to expand its platform into pathology, genomics, and general medicine, with the long-term goal of becoming the infrastructure layer for AI adoption across healthcare.
